LKB1 inactivation modulates chromatin accessibility to drive metastatic progression – Nature Cell Biology
Pierce et al perform genome-wide CRISPR screening and identify LKB1 as a regulator of chromatin accessibility and metastatic progression in lung cancer through a mechanism of SOX17-mediated epigenetic changes.